Tipifarnib
N/A
Report date: 2026/03/31 20:00:21
NME
Base Information
Drug NameTipifarnib
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[79]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[22]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohnson & Johnson
China Registration ClassN/A
Develop Information
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)UT Health San AntonioUniversity Of Bologna +[14]
Active Indications +[20]
Inactive Indications +[59]